Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | ACHE | P22303 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA5A | P35218 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.36 |
| ▸ | HTT | P42858 | 3/20 | 0.36 |
| ▸ | ATM | Q13315 | 3/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.36 |
| ▸ | GAA | P10253 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | PKM | P14618 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4926591 | 0.81 | TSHR (0.50) | TSHRTDP1ACHENPC1MAPT | |
| SCHEMBL43182 | 0.79 | ALDH1A1 (0.44) | TSHRCYP2A6NPC1MAPTRAB9A | |
| SCHEMBL547849 | 0.78 | TSHR (0.52) | TSHRCYP2A6TDP1ACHENPC1 | |
| SCHEMBL7753917 | 0.77 | ESR1 (0.56) | TSHRNPC1MAPTRAB9ACA1 | |
| SCHEMBL3160077 | 0.77 | CES2 (0.44) | TSHRALDH1A1CES2CES1 | |
| SCHEMBL1806495 | 0.77 | MEN1 (0.52) | TSHRCYP2A6NPC1MAPTRAB9A | |
| SCHEMBL3053977 | 0.77 | CYP2A6 (0.40) | TSHRCYP2A6NPC1MAPTRAB9A | |
| SCHEMBL14820709 | 0.77 | TP53 (0.35) | TSHRNPC1MAPTRAB9AALDH1A1 | |
| SCHEMBL186764 | 0.77 | RAB9A (0.42) | ACHENPC1MAPTRAB9AALDH1A1 | |
| SCHEMBL9858415 | 0.77 | TSHR (0.52) | TSHRCYP2A6TDP1ACHENPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250280857-A1 | DEGRADATION-RESISTANT ALDEHYDE-CONTAINING COMPOSITIONS | ZOOMESSENCE INC (US) | 2025-09-11 | — | — | US | claimed |
| CN-119136683-A | Degradation resistant aldehyde-containing compositions | 祖姆森斯有限公司 | 2024-12-13 | — | — | CN | claimed |
| WO-2023215706-A1 | DEGRADATION-RESISTANT ALDEHYDE-CONTAINING COMPOSITIONS | ZoomEssence, Inc. (US) | 2023-11-09 | — | — | WO | claimed |
| US-20250280857-A1 | DEGRADATION-RESISTANT ALDEHYDE-CONTAINING COMPOSITIONS | ZOOMESSENCE INC (US) | 2025-09-11 | — | — | US | disclosed |
| CN-119136683-A | Degradation resistant aldehyde-containing compositions | 祖姆森斯有限公司 | 2024-12-13 | — | — | CN | disclosed |
| WO-2023215706-A1 | DEGRADATION-RESISTANT ALDEHYDE-CONTAINING COMPOSITIONS | ZoomEssence, Inc. (US) | 2023-11-09 | — | — | WO | disclosed |
| EP-4177249-A1 | IMMUNOMODULATOR | Hitgen Inc. (CN) | 2023-05-10 | — | — | EP | disclosed |
| US-20150246097-A9 | Polyalkylene Polymer Compounds and Uses Thereof | BIOGEN IDEC MA INC. (US) | 2015-09-03 | — | — | US | disclosed |
| US-20150132259-A1 | Polyalkylene Polymer Compounds and Uses Thereof | BIOGEN IDEC MA INC. (US) | 2015-05-14 | — | — | US | disclosed |
| US-8148371-B2 | Adenine compound and use thereof | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2012-04-03 | — | — | US | disclosed |
| US-7964599-B2 | Therapeutic compounds | ALLERGAN, INC. (US) | 2011-06-21 | — | — | US | disclosed |
| EP-1408036-B1 | PROCESS FOR PRODUCING BENZOFURAN DERIVATIVE | TAKEDA PHARMACEUTICAL (JP) | 2008-08-27 | — | — | EP | disclosed |
| US-7323577-B2 | Process for producing benzofuran derivative | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2008-01-29 | — | — | US | disclosed |
| US-20070259929-A1 | Therapeutic Compounds | ALLERGAN, INC. | 2007-11-08 | — | — | US | disclosed |
| US-20060142598-A1 | Process for producing benzofuran derivative | TAWADA HIROYUKI | 2006-06-29 | — | — | US | disclosed |
| US-7034166-B2 | Process for producing benzofuran derivative | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2006-04-25 | — | — | US | disclosed |
| US-20040210066-A1 | Process for producing benzofuran derivative | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2004-10-21 | — | — | US | disclosed |
| EP-1408036-A1 | PROCESS FOR PRODUCING BENZOFURAN DERIVATIVE | Takeda Chemical Industries, Ltd. (JP) | 2004-04-14 | — | — | EP | disclosed |
| WO-1999015524-A1 | THIAZOLE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1999-04-01 | — | — | WO | disclosed |
| US-4352748-A | Novel acyl-polyalkylindan compounds and the use thereof as a base for perfume, as well as perfume compositions | NAARDEN INTERNATIONAL N.V. (NL) | 1982-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040210066-A1 | Process for producing benzofuran derivative | IWS1, HAT1, BRD1 | TSHR 3323/4885CYP2A6 361/4885TDP1 4618/4885 |
| US-20150246097-A9 | Polyalkylene Polymer Compounds and Uses Thereof | HAVCR2, TLR3, CCR8 | TSHR 4162/4885CYP2A6 3174/4885TDP1 3972/4885 |
| US-20070259929-A1 | Therapeutic Compounds | PIGO, CYC1, COXFA4L2 | TSHR 3918/4885CYP2A6 2109/4885TDP1 1880/4885 |
| US-20150132259-A1 | Polyalkylene Polymer Compounds and Uses Thereof | HAVCR2, TLR3, CCR8 | TSHR 4162/4885CYP2A6 3174/4885TDP1 3972/4885 |
| US-20060142598-A1 | Process for producing benzofuran derivative | AHR, CBR3, HAT1 | TSHR 2262/4885CYP2A6 320/4885TDP1 4682/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.